ASP Isotopes

ASP Isotopes Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of ASP Isotopes (ASPI) as of Nov 18, 2026 is -83.14. In the previous year, Cash Conversion Cycle (CCC) was -74.81 — a change of 11.14% (lower).

Cash Conversion Cycle

-83.14

YoY

11.14%

Last updated:

Cash Conversion Cycle (CCC) of ASP Isotopes is 2025 -83.14 . Cash Conversion Cycle (CCC) of ASP Isotopes was 2024 -74.81 . It decreases by 11.14% lower compared to the previous year.

The ASP Isotopes Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2021
-1,124.22 USD
Jan 1, 2022
-6,814.66 USD
Jan 1, 2023
-1,197.57 USD
Jan 1, 2024
-74.81 USD
Jan 1, 2025
-83.14 USD
The ASP Isotopes Cash Conversion Cycle history
YEARCash Conversion CycleYoY
-83.14+11.14%
-74.81-93.75%
-1,197.57-82.43%
-6,814.66+506.17%
-1,124.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ASP Isotopes Stock analysis

What does ASP Isotopes do? ASP Isotopes, Inc. generates revenue through the development and commercialization of enriched isotopes using its Aerodynamic Separation Process (ASP technology). The company focuses on producing Carbon-14 (C-14), Molybdenum-100 (Mo-100), and Silicon-28 (Si-28) for specialized markets, with plans to expand into Uranium-235 (U-235) for the nuclear energy sector. Its subsidiaries, ASP Isotopes Guernsey Limited and Enriched Energy LLC, handle high-value isotope production and uranium development, respectively. The company licenses ASP technology from Klydon Proprietary Ltd for all isotope-related activities. The target customers for C-14, Mo-100, and Si-28 are highly specialized end markets requiring low-volume, high-value isotopes. Enriched Energy LLC specifically targets the nuclear energy market with uranium products. ASP Isotopes Guernsey Limited focuses on niche applications where isotope enrichment is critical, such as medical and industrial uses. The company’s revenue model relies on the sale of these enriched isotope products to specialized industries rather than mass-market consumers. ASP Isotopes, Inc. operates under a pre-commercial stage, meaning it is still developing its production capabilities and has not yet achieved full-scale commercialization. The company’s initial revenue streams will come from the sale of C-14, Mo-100, and Si-28, with future expansion into U-235 expected to diversify its product portfolio. The Aerodynamic Separation Process (ASP technology) is central to its business model, enabling the enrichment of natural isotopes into higher concentration products for specialized applications. ASP Isotopes is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ASP Isotopes stock

Cash Conversion Cycle (CCC) of ASP Isotopes is -83.14 in 2025.

Cash Conversion Cycle (CCC) of ASP Isotopes changed from -74.81 to -83.14, representing a 11.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) ASP Isotopes since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s ASP Isotopes with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ASP Isotopes

All Key Metrics — ASP Isotopes